Leiomyosarcoma of Urinary Bladder Following Cyclophosphamide Therapy: Report of Two Cases View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2003-05-01

AUTHORS

C Tanguay, I Harvey, M Houde, J R Srigley, B Têtu

ABSTRACT

Leiomyosarcoma of urinary bladder is rare, although it is the most common mesenchymal tumor in adults. We report two cases of this tumor following cyclophosphamide therapy. The first case is from a 53-year-old man with Wegener's granulomatosis treated for 6 years with cyclophosphamide. He presented with painless hematuria, and the initial biopsy of the bladder tumor revealed a malignant spindle cell neoplasm. A final diagnosis of leiomyosarcoma was made on radical cystoprostatectomy. The second example is from a 21-year-old man who had received cyclophosphamide in early infancy for a bilateral retinoblastoma. He also presented with painless hematuria, and a bladder tumor was resected transurethrally and diagnosed as leiomyosarcoma. He underwent partial cystectomy two months later. Cyclophosphamide, when used for a neoplastic or non-neoplastic condition, is associated with an increased risk of developing bladder cancer. The distribution of histologic subtypes differs from that seen in spontaneous bladder tumors. A review of the literature shows an increased proportion of squamous cell carcinomas and sarcomas, especially leiomyosarcomas in cyclophosphamide exposed patients. Acrolein, a cytotoxic metabolite of cyclophosphamide excreted in urine, is regarded as the most likely causative agent. More... »

PAGES

512-514

Identifiers

URI

http://scigraph.springernature.com/pub.10.1097/01.mp.0000068237.38715.d9

DOI

http://dx.doi.org/10.1097/01.mp.0000068237.38715.d9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1046197547

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12748258


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclophosphamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Granulomatosis with Polyangiitis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunosuppressive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leiomyosarcoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms, Second Primary", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retinoblastoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Urinary Bladder Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pathology, CHUQ, H\u00f4tel-Dieu de Qu\u00e9bec, Laval University, Victoriaville, Quebec", 
          "id": "http://www.grid.ac/institutes/grid.417661.3", 
          "name": [
            "Department of Pathology, CHUQ, H\u00f4tel-Dieu de Qu\u00e9bec, Laval University, Victoriaville, Quebec"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tanguay", 
        "givenName": "C", 
        "id": "sg:person.01073552414.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073552414.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, CHUQ, H\u00f4tel-Dieu de Qu\u00e9bec, Laval University, Victoriaville, Quebec", 
          "id": "http://www.grid.ac/institutes/grid.417661.3", 
          "name": [
            "Department of Pathology, CHUQ, H\u00f4tel-Dieu de Qu\u00e9bec, Laval University, Victoriaville, Quebec"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Harvey", 
        "givenName": "I", 
        "id": "sg:person.0772132534.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772132534.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4tel-Dieu d'Arthabaska, Victoriaville, Quebec", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "H\u00f4tel-Dieu d'Arthabaska, Victoriaville, Quebec"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Houde", 
        "givenName": "M", 
        "id": "sg:person.01211627567.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211627567.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Credit Valley Hospital, Mississauga, Ontario", 
          "id": "http://www.grid.ac/institutes/grid.413270.3", 
          "name": [
            "Credit Valley Hospital, Mississauga, Ontario"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Srigley", 
        "givenName": "J R", 
        "id": "sg:person.0776223417.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0776223417.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, CHUQ, H\u00f4tel-Dieu de Qu\u00e9bec, Laval University, Victoriaville, Quebec", 
          "id": "http://www.grid.ac/institutes/grid.417661.3", 
          "name": [
            "Department of Pathology, CHUQ, H\u00f4tel-Dieu de Qu\u00e9bec, Laval University, Victoriaville, Quebec"
          ], 
          "type": "Organization"
        }, 
        "familyName": "T\u00eatu", 
        "givenName": "B", 
        "id": "sg:person.0612111203.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612111203.07"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2003-05-01", 
    "datePublishedReg": "2003-05-01", 
    "description": "Leiomyosarcoma of urinary bladder is rare, although it is the most common mesenchymal tumor in adults. We report two cases of this tumor following cyclophosphamide therapy. The first case is from a 53-year-old man with Wegener's granulomatosis treated for 6 years with cyclophosphamide. He presented with painless hematuria, and the initial biopsy of the bladder tumor revealed a malignant spindle cell neoplasm. A final diagnosis of leiomyosarcoma was made on radical cystoprostatectomy. The second example is from a 21-year-old man who had received cyclophosphamide in early infancy for a bilateral retinoblastoma. He also presented with painless hematuria, and a bladder tumor was resected transurethrally and diagnosed as leiomyosarcoma. He underwent partial cystectomy two months later. Cyclophosphamide, when used for a neoplastic or non-neoplastic condition, is associated with an increased risk of developing bladder cancer. The distribution of histologic subtypes differs from that seen in spontaneous bladder tumors. A review of the literature shows an increased proportion of squamous cell carcinomas and sarcomas, especially leiomyosarcomas in cyclophosphamide exposed patients. Acrolein, a cytotoxic metabolite of cyclophosphamide excreted in urine, is regarded as the most likely causative agent.", 
    "genre": "article", 
    "id": "sg:pub.10.1097/01.mp.0000068237.38715.d9", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1098208", 
        "issn": [
          "0893-3952", 
          "1530-0285"
        ], 
        "name": "Modern Pathology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "16"
      }
    ], 
    "keywords": [
      "bladder tumors", 
      "cyclophosphamide therapy", 
      "painless hematuria", 
      "urinary bladder", 
      "malignant spindle cell neoplasm", 
      "common mesenchymal tumors", 
      "squamous cell carcinoma", 
      "non-neoplastic conditions", 
      "spindle cell neoplasm", 
      "likely causative agent", 
      "Wegener's granulomatosis", 
      "radical cystoprostatectomy", 
      "initial biopsy", 
      "histologic subtype", 
      "mesenchymal tumors", 
      "cell carcinoma", 
      "final diagnosis", 
      "bladder cancer", 
      "cell neoplasms", 
      "bilateral retinoblastoma", 
      "cyclophosphamide", 
      "early infancy", 
      "leiomyosarcoma", 
      "tumors", 
      "two months", 
      "causative agent", 
      "granulomatosis", 
      "hematuria", 
      "first case", 
      "bladder", 
      "therapy", 
      "cytotoxic metabolites", 
      "men", 
      "cystoprostatectomy", 
      "biopsy", 
      "patients", 
      "carcinoma", 
      "sarcoma", 
      "neoplasms", 
      "cancer", 
      "subtypes", 
      "diagnosis", 
      "retinoblastoma", 
      "cases", 
      "months", 
      "urine", 
      "adults", 
      "risk", 
      "infancy", 
      "report", 
      "metabolites", 
      "review", 
      "years", 
      "agents", 
      "proportion", 
      "acrolein", 
      "literature", 
      "conditions", 
      "distribution", 
      "example", 
      "second example"
    ], 
    "name": "Leiomyosarcoma of Urinary Bladder Following Cyclophosphamide Therapy: Report of Two Cases", 
    "pagination": "512-514", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1046197547"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1097/01.mp.0000068237.38715.d9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12748258"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1097/01.mp.0000068237.38715.d9", 
      "https://app.dimensions.ai/details/publication/pub.1046197547"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_374.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1097/01.mp.0000068237.38715.d9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1097/01.mp.0000068237.38715.d9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1097/01.mp.0000068237.38715.d9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1097/01.mp.0000068237.38715.d9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1097/01.mp.0000068237.38715.d9'


 

This table displays all metadata directly associated to this object as RDF triples.

204 TRIPLES      20 PREDICATES      98 URIs      90 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1097/01.mp.0000068237.38715.d9 schema:about N4b138e826936488c9e68dd66e274637b
2 N5a9f6b86fac04b93952ec1a9f9d7d9b7
3 N5ef05269bc4d4455811f155fc0f4f8f1
4 N68a7d9abbb3e44ccb00db8467a479b6f
5 N761c251904644d60abf4e64e772d6c88
6 N767fa1d8b0a94300bf0a958ba14d2eb7
7 N82d672b3ca8a4457a6f7e78475a63202
8 N8e4bfe9d3fca47b181026eeefe911b09
9 Na6ff6cba34a940758b7f5ac1e5f885c5
10 Nbe8ad491528443f8971386564d2267ec
11 Ndc8c27604c5e45698c944649e8853749
12 Nebde0399dd514b95969ef236eff1908d
13 anzsrc-for:11
14 anzsrc-for:1112
15 schema:author N04bed70c9179459584f3bb2d30da2079
16 schema:datePublished 2003-05-01
17 schema:datePublishedReg 2003-05-01
18 schema:description Leiomyosarcoma of urinary bladder is rare, although it is the most common mesenchymal tumor in adults. We report two cases of this tumor following cyclophosphamide therapy. The first case is from a 53-year-old man with Wegener's granulomatosis treated for 6 years with cyclophosphamide. He presented with painless hematuria, and the initial biopsy of the bladder tumor revealed a malignant spindle cell neoplasm. A final diagnosis of leiomyosarcoma was made on radical cystoprostatectomy. The second example is from a 21-year-old man who had received cyclophosphamide in early infancy for a bilateral retinoblastoma. He also presented with painless hematuria, and a bladder tumor was resected transurethrally and diagnosed as leiomyosarcoma. He underwent partial cystectomy two months later. Cyclophosphamide, when used for a neoplastic or non-neoplastic condition, is associated with an increased risk of developing bladder cancer. The distribution of histologic subtypes differs from that seen in spontaneous bladder tumors. A review of the literature shows an increased proportion of squamous cell carcinomas and sarcomas, especially leiomyosarcomas in cyclophosphamide exposed patients. Acrolein, a cytotoxic metabolite of cyclophosphamide excreted in urine, is regarded as the most likely causative agent.
19 schema:genre article
20 schema:isAccessibleForFree true
21 schema:isPartOf N855c293d985444f5bdcf0aa2a608db5f
22 Na977c1e48ddc429ca5e3fb0d3d33b56e
23 sg:journal.1098208
24 schema:keywords Wegener's granulomatosis
25 acrolein
26 adults
27 agents
28 bilateral retinoblastoma
29 biopsy
30 bladder
31 bladder cancer
32 bladder tumors
33 cancer
34 carcinoma
35 cases
36 causative agent
37 cell carcinoma
38 cell neoplasms
39 common mesenchymal tumors
40 conditions
41 cyclophosphamide
42 cyclophosphamide therapy
43 cystoprostatectomy
44 cytotoxic metabolites
45 diagnosis
46 distribution
47 early infancy
48 example
49 final diagnosis
50 first case
51 granulomatosis
52 hematuria
53 histologic subtype
54 infancy
55 initial biopsy
56 leiomyosarcoma
57 likely causative agent
58 literature
59 malignant spindle cell neoplasm
60 men
61 mesenchymal tumors
62 metabolites
63 months
64 neoplasms
65 non-neoplastic conditions
66 painless hematuria
67 patients
68 proportion
69 radical cystoprostatectomy
70 report
71 retinoblastoma
72 review
73 risk
74 sarcoma
75 second example
76 spindle cell neoplasm
77 squamous cell carcinoma
78 subtypes
79 therapy
80 tumors
81 two months
82 urinary bladder
83 urine
84 years
85 schema:name Leiomyosarcoma of Urinary Bladder Following Cyclophosphamide Therapy: Report of Two Cases
86 schema:pagination 512-514
87 schema:productId N0c4b81409a5b4614897aecae974af672
88 N0e407a3182b348f6bc52c38ce67f5705
89 Nc17e9dc6e70d4895b714a2e0bd536032
90 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046197547
91 https://doi.org/10.1097/01.mp.0000068237.38715.d9
92 schema:sdDatePublished 2022-12-01T06:23
93 schema:sdLicense https://scigraph.springernature.com/explorer/license/
94 schema:sdPublisher N74e8d928e6664833adb833b39f6029fc
95 schema:url https://doi.org/10.1097/01.mp.0000068237.38715.d9
96 sgo:license sg:explorer/license/
97 sgo:sdDataset articles
98 rdf:type schema:ScholarlyArticle
99 N04bed70c9179459584f3bb2d30da2079 rdf:first sg:person.01073552414.44
100 rdf:rest N0b668dbd795c4a22b1a04f95485d654d
101 N0b668dbd795c4a22b1a04f95485d654d rdf:first sg:person.0772132534.22
102 rdf:rest Nf065e783f0b7401580356b35e1577487
103 N0c4b81409a5b4614897aecae974af672 schema:name dimensions_id
104 schema:value pub.1046197547
105 rdf:type schema:PropertyValue
106 N0e407a3182b348f6bc52c38ce67f5705 schema:name doi
107 schema:value 10.1097/01.mp.0000068237.38715.d9
108 rdf:type schema:PropertyValue
109 N300c00aced89439b835b168887161caf rdf:first sg:person.0612111203.07
110 rdf:rest rdf:nil
111 N4b138e826936488c9e68dd66e274637b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Antineoplastic Combined Chemotherapy Protocols
113 rdf:type schema:DefinedTerm
114 N4bed004f183f469b96aa1b2ca3f079dc rdf:first sg:person.0776223417.96
115 rdf:rest N300c00aced89439b835b168887161caf
116 N5a9f6b86fac04b93952ec1a9f9d7d9b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Neoplasms, Second Primary
118 rdf:type schema:DefinedTerm
119 N5ef05269bc4d4455811f155fc0f4f8f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Cyclophosphamide
121 rdf:type schema:DefinedTerm
122 N68a7d9abbb3e44ccb00db8467a479b6f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Male
124 rdf:type schema:DefinedTerm
125 N74e8d928e6664833adb833b39f6029fc schema:name Springer Nature - SN SciGraph project
126 rdf:type schema:Organization
127 N761c251904644d60abf4e64e772d6c88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Leiomyosarcoma
129 rdf:type schema:DefinedTerm
130 N767fa1d8b0a94300bf0a958ba14d2eb7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Humans
132 rdf:type schema:DefinedTerm
133 N82d672b3ca8a4457a6f7e78475a63202 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Middle Aged
135 rdf:type schema:DefinedTerm
136 N855c293d985444f5bdcf0aa2a608db5f schema:volumeNumber 16
137 rdf:type schema:PublicationVolume
138 N8e4bfe9d3fca47b181026eeefe911b09 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Retinoblastoma
140 rdf:type schema:DefinedTerm
141 Na6ff6cba34a940758b7f5ac1e5f885c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Urinary Bladder Neoplasms
143 rdf:type schema:DefinedTerm
144 Na977c1e48ddc429ca5e3fb0d3d33b56e schema:issueNumber 5
145 rdf:type schema:PublicationIssue
146 Nbe8ad491528443f8971386564d2267ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Granulomatosis with Polyangiitis
148 rdf:type schema:DefinedTerm
149 Nc17e9dc6e70d4895b714a2e0bd536032 schema:name pubmed_id
150 schema:value 12748258
151 rdf:type schema:PropertyValue
152 Ndc8c27604c5e45698c944649e8853749 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Immunosuppressive Agents
154 rdf:type schema:DefinedTerm
155 Nebde0399dd514b95969ef236eff1908d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Adult
157 rdf:type schema:DefinedTerm
158 Nf065e783f0b7401580356b35e1577487 rdf:first sg:person.01211627567.17
159 rdf:rest N4bed004f183f469b96aa1b2ca3f079dc
160 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
161 schema:name Medical and Health Sciences
162 rdf:type schema:DefinedTerm
163 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
164 schema:name Oncology and Carcinogenesis
165 rdf:type schema:DefinedTerm
166 sg:journal.1098208 schema:issn 0893-3952
167 1530-0285
168 schema:name Modern Pathology
169 schema:publisher Springer Nature
170 rdf:type schema:Periodical
171 sg:person.01073552414.44 schema:affiliation grid-institutes:grid.417661.3
172 schema:familyName Tanguay
173 schema:givenName C
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073552414.44
175 rdf:type schema:Person
176 sg:person.01211627567.17 schema:affiliation grid-institutes:None
177 schema:familyName Houde
178 schema:givenName M
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211627567.17
180 rdf:type schema:Person
181 sg:person.0612111203.07 schema:affiliation grid-institutes:grid.417661.3
182 schema:familyName Têtu
183 schema:givenName B
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612111203.07
185 rdf:type schema:Person
186 sg:person.0772132534.22 schema:affiliation grid-institutes:grid.417661.3
187 schema:familyName Harvey
188 schema:givenName I
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772132534.22
190 rdf:type schema:Person
191 sg:person.0776223417.96 schema:affiliation grid-institutes:grid.413270.3
192 schema:familyName Srigley
193 schema:givenName J R
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0776223417.96
195 rdf:type schema:Person
196 grid-institutes:None schema:alternateName Hôtel-Dieu d'Arthabaska, Victoriaville, Quebec
197 schema:name Hôtel-Dieu d'Arthabaska, Victoriaville, Quebec
198 rdf:type schema:Organization
199 grid-institutes:grid.413270.3 schema:alternateName Credit Valley Hospital, Mississauga, Ontario
200 schema:name Credit Valley Hospital, Mississauga, Ontario
201 rdf:type schema:Organization
202 grid-institutes:grid.417661.3 schema:alternateName Department of Pathology, CHUQ, Hôtel-Dieu de Québec, Laval University, Victoriaville, Quebec
203 schema:name Department of Pathology, CHUQ, Hôtel-Dieu de Québec, Laval University, Victoriaville, Quebec
204 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...